融合生検のアジア太平洋市場2020-2026:最終用途別(診断センター、病院、外来診療センター)、経路別、地域別

◆英語タイトル:Asia Pacific Fusion Biopsy Market By End Use (Diagnostic centers, Hospitals and Ambulatory care centers), By Route (Transperineal and Transrectal), By Country, Industry Analysis and Forecast, 2020 - 2026
◆商品コード:KBV20OCT189
◆発行会社(リサーチ会社):KBV Research
◆発行日:2020年8月31日
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ、カナダ、メキシコ、ロシア、ドイツ、英国、フランス、スペイン、イタリア、中国、日本、インド、韓国、シンガポール、マレーシア、ブラジル、アルゼンチン、アラブ首長国連邦、サウジアラビア、南アフリカ、ナイジェリア
◆販売価格オプション(消費税別)
Single User(1名様利用)USD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Global License(法人利用)USD2,520 ⇒換算¥272,160見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はKBV Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
KBV Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査レポートでは、融合生検のアジア太平洋市場について、市場範囲・調査手法、市場概要、市場動向、最終用途別(診断センター、病院、外来診療センター)分析、経路別分析、地域別分析、企業概要などを総合的、多面的に調査・分析しました。
・市場範囲・調査手法
・市場概要
・市場動向
・融合生検のアジア太平洋市場規模:最終用途別(診断センター、病院、外来診療センター)
・融合生検のアジア太平洋市場規模:経路別
・融合生検のアジア太平洋市場規模:地域別
・企業概要
【レポートの概要】

The Asia Pacific Fusion Biopsy Market would witness market growth of 12.9% CAGR during the forecast period (2020-2026).

Asia Pacific is expected to show fastest growth rate in the forecasted years. The rising awareness among urologists about the functions and features as well as sensitivity and specificity of the targeted MR/Ultrasound biopsy while performing a prostate biopsy is likely to drive the market. Furthermore, the growing private sector participation in healthcare mainly in countries like India, China, and Japan that own high purchasing capabilities are also anticipated to have a positive impact on the fusion biopsy market.

The major companies are emphasizing more on R&D to develop advancement in hardware and software solutions to rationalize the workflow of the targeted MRI/US fusion biopsy. The novel version had an additional accessory of software and hardware to perform a transperineal fusion biopsy. The market players are shifting their attention to various strategies like product launches, collaborations mergers, and acquisitions, strengthening distribution networks, and trying to enter untapped markets, particularly in the developing economies to reinforce their market presence.

Ambulatory care centers are likely to grow at a fast rate in the foreseeable period of time. The increasing occurrence of prostate cancer in rural areas where there is limited access to healthcare service is one of the factors estimated to drive the growth of the market of fusion biopsy. Furthermore, the highly portable and low-cost MRI has been introduced and is anticipated to improve the adoption rate of the targeted MR/Ultrasound biopsy even in the ambulatory care centers, therefore, likely to boost the growth of the overall market.

Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.

The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.

Scope of the Study
Market Segmentation:

By End Use
• Diagnostic centers
• Hospitals
• Ambulatory care centers

By Route
• Transperineal
• Transrectal

By Country
• China
• Japan
• India
• South Korea
• Singapore
• Australia
• Rest of Asia Pacific

Companies Profiled
• Koninklijke Philips N.V.
• Hitachi, Ltd.
• Baxter International, Inc. (MedCom)
• Esaote SpA
• Eigen
• KOELIS, Inc.
• Focal Healthcare, Inc.
• UC-Care Medical Systems Ltd.

Unique Offerings from KBV Research
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

【レポートの目次】

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Fusion Biopsy Market, by End Use
1.4.2 Asia Pacific Fusion Biopsy Market, by Route
1.4.3 Asia Pacific Fusion Biopsy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent market developments in Fusion Biopsy Market
Chapter 4. Asia Pacific Fusion Biopsy Market by End Uses
4.1 Asia Pacific Diagnostic centers Market by Country
4.2 Asia Pacific Hospitals Market by Country
4.3 Asia Pacific Ambulatory care centers Market by Country
Chapter 5. Asia Pacific Fusion Biopsy Market by Route
5.1 Asia Pacific Transperineal Market by Country
5.2 Asia Pacific Transrectal Market by Country
Chapter 6. Asia Pacific Fusion Biopsy Market by Country
6.1 China Fusion Biopsy Market
6.1.1 China Fusion Biopsy Market by End Uses
6.1.2 China Fusion Biopsy Market by Route
6.2 India Fusion Biopsy Market
6.2.1 India Fusion Biopsy Market by End Uses
6.2.2 India Fusion Biopsy Market by Route
6.3 Japan Fusion Biopsy Market
6.3.1 Japan Fusion Biopsy Market by End Uses
6.3.2 Japan Fusion Biopsy Market by Route
6.4 Australia Fusion Biopsy Market
6.4.1 Australia Fusion Biopsy Market by End Uses
6.4.2 Australia Fusion Biopsy Market by Route
6.5 South Korea Fusion Biopsy Market
6.5.1 South Korea Fusion Biopsy Market by End Uses
6.5.2 South Korea Fusion Biopsy Market by Route
6.6 Singapore Fusion Biopsy Market
6.6.1 Singapore Fusion Biopsy Market by End Uses
6.6.2 Singapore Fusion Biopsy Market by Route
6.7 Rest of Asia Pacific Fusion Biopsy Market
6.7.1 Rest of Asia Pacific Fusion Biopsy Market by End Uses
6.7.2 Rest of Asia Pacific Fusion Biopsy Market by Route
Chapter 7. Company Profiles
7.1 Koninklijke Philips N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.2 Hitachi, Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Baxter International, Inc. (MedCom)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.4 Esaote SpA
7.4.1 Company Overview
7.5 Eigen
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 KOELIS, Inc.
7.6.1 Company Overview
7.7 Focal Healthcare, Inc.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Approvals:
7.8 UC-Care Medical Systems Ltd.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[融合生検のアジア太平洋市場2020-2026:最終用途別(診断センター、病院、外来診療センター)、経路別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆